SynthesisFrontiers in medicine2026
Effects of Wuqinxi on joint function, muscle strength, and balance function in patients with knee osteoarthritis: a systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In recent years, an increasing number of studies have demonstrated the potential therapeutic effects of traditional Chinese exercises in the treatment of knee osteoarthritis (KOA). However, the effectiveness of Wuqinxi (WQX) for patients with KOA remains a subject of debate. This study aimed to systematically evaluate the effects of WQX on joint function, muscle strength, balance function, and pain in patients with KOA. Methods: A systematic search was conducted in seven electronic databases, including PubMed, Cochrane, EMBASE, Web of Science, CNKI, Wanfang, and VIP, from database inception to November 2025 to identify all randomized controlled trials (RCTs) on WQX for the treatment of KOA. Two reviewers independently extracted data and assessed the risk of bias using the Cochrane tool. Outcome measures included joint function scores [Lysholm and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)], peak torque of the flexor and extensor muscles of the knee, balance function [including dynamic fall index (DFI), time to contact test (TCT), and overall stability index (OSI)], and Visual Analog Scale (VAS) scores. Subgroup, sensitivity, and publication-bias analyses were also performed. The certainty of the evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Results: A total of 9 trials involving 809 participants were included. The results showed that WQX significantly improved Lysholm scores [mean difference (MD) = 6.34, 95% confidence interval (CI): 2.32 to 10.36, Conclusion: WQX may be an effective complementary and alternative therapy for KOA, improving joint function and muscle strength in patients with KOA. However, the available evidence is limited by geographic concentration, clinical heterogeneity, risk of bias, and low-to-moderate certainty for several outcomes. Therefore, further high-quality RCTs are needed to validate these findings. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251268070, identifier (CRD420251047102).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.